|Articles|March 1, 2003
Little Pill; Big Deal
Chances are many of your older female patients have either stopped using hormone replacement therapy or are still mulling over the pros and cons since the Women's Health Initiative found conflicting data about its health benefits and risks.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians See Intersection of Weight Loss and Facial Aging
2
The “6-7” Advances for Dermatologists to Look Forward to in 2026
3
Q&A: Saami Khalifian, MD, FAAD, on Integrating BOTOX Cosmetic into Lower Face and Neck Rejuvenation
4
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
5














